Mai Kadry | Global Health | Editorial Board Member

Published on by Health Scientists

Assist. Prof. Dr. Mai Kadry | Global Health | Editorial Board Member 

Research Scientist | National Research Center | Egypt

Mai O. Kadry is a distinguished researcher at the National Research Centre in Giza, Egypt, recognized for her multidisciplinary contributions across metabolomics, molecular oncology, nanomedicine, toxicology, and women’s health research. Her scientific portfolio reflects a sustained commitment to unraveling the biochemical and molecular mechanisms underpinning complex diseases, with a particular focus on metabolic disorders, cancer progression, reproductive toxicology, and innovative therapeutic strategies. Through a substantial body of peer-reviewed publications, she has advanced understanding of how metabolic signatures, genomic interactions, and molecular signaling pathways can be leveraged to improve disease diagnosis, treatment response, and therapeutic safety. Her work frequently integrates serum metabolomics, network pharmacology, lipidomics, nanostructure-based drug delivery, and experimental validation models, enabling a comprehensive systems-level view of disease processes. She has collaborated extensively with national and international scientists, contributing to multidisciplinary studies on phytotherapeutics for endocrine disorders, nanoscale interventions to mitigate chemotherapeutic toxicity, and molecular crosstalk driving drug resistance in cancer cells. Her authorship and citation footprint reflect broad scholarly engagement, while her active participation in multi-institutional teams has supported knowledge exchange and capacity building within the biomedical research community. Kadry’s investigations into natural product therapeutics, oxidative brain injury mechanisms, autophagy regulation, and emerging RNA-based biomarkers contribute to public health and precision medicine, offering insights with potential translational relevance to women’s health, oncology, toxicology, and environmental exposure science. Collectively, her work demonstrates a strong commitment to scientific innovation, interdisciplinary integration, and the societal importance of developing safer, more effective therapeutic approaches that align with global health priorities. She has 462 citations from 50 documents with an h-index of 12.

Profiles: Scopus | ORCID

Featured Publications

1. Kadry, M., Author, A. A., Author, B. B., … (2025). Exploring the therapeutic potential of marjoram (Origanum majorana L.) in polycystic ovary syndrome: Insights from serum metabolomics, network pharmacology and experimental validation.

2. Kadry, M., & Author, A. A. (2025). Novel insights into SNORD-78 and miR-122-5P: The predicted diagnostic indexes of lung cancer—Drug-loaded liposome formulations competing methylcholanthrene-induced lung cancer.

3. Kadry, M., Author, A. A., Author, B. B., Author, C. C., & Author, D. D. (2025). Oxidative brain injury ascending from DMBA: Metabolomics and BRAF3/FKBR/A2m molecular signaling crosstalk.

4. Kadry, M., Author, A. A., Author, B. B., … (2025). Metabolomics integrated genomics approach: Understanding multidrug resistance phenotype in MCF-7 breast cancer cells exposed to doxorubicin and ABCA1/EGFR/PI3K/PTEN crosstalk.

5. Kadry, M., Author, A. A., & Author, B. B. (2025). Titanium nanostructure mitigating doxorubicin-induced testicular toxicity in rats via regulating major autophagy signaling pathways.

Wenxin Xue | Public Health | Best Researcher Award

Published on by Health Scientists

Prof. Wenxin Xue | Public Health | Best Researcher Award

clinical pharmacist | Emergency General Hospital | China

Wenxin Xue is a distinguished chief pharmacist and pharmacology scholar whose career reflects a sustained commitment to advancing evidence-based clinical pharmacy, interdisciplinary healthcare, and translational pharmacological research. With a strong foundation as a PhD-trained pharmacologist, clinical pharmacist, graduate tutor, and head of a clinical pharmacy group, he has contributed extensively to optimizing therapeutic strategies, enhancing medication safety, and improving patient outcomes across complex clinical settings. His expertise spans vascular pharmacology, endocrine-metabolic disorders, renal protection, infectious disease therapeutics, immune-oncology, and health technology assessment, demonstrated through a substantial portfolio of peer-reviewed publications with significant citation visibility and coverage across both basic and clinical research. His scholarly work includes investigations on endothelial dysfunction, adrenergic receptor mechanisms, statin therapy, immune checkpoint inhibitor outcomes, infectious disease precision medication, adverse reaction surveillance, and meta-analytic evaluations of therapeutic efficacy, all of which have supported improved clinical decision-making and policy development. As a reviewer and editorial board member for multiple international and national journals, he plays a key role in shaping scientific discourse and ensuring research quality, while his involvement in multidisciplinary teams for weight management, geriatrics, and infectious diseases highlights his leadership in collaborative, patient-centered care. His research initiatives integrate pharmacodynamics, precision medicine, and clinical epidemiology, contributing to strengthened drug management standards and innovative therapeutic approaches adopted within hospital systems. Beyond research, his service as an expert reviewer for scientific and medical grant agencies reflects his influence on strategic research funding and healthcare innovation. Collectively, his academic output, professional leadership, and cross-disciplinary engagements underscore a career dedicated to advancing pharmacy practice, promoting rational drug use, and supporting the evolution of modern clinical pharmacology to benefit patients and healthcare systems. The researcher has 8 citations from 8 documents with an h-index of 2.

Profile: Scopus

Featured Publications

1. Xue, W. (Year). Distribution and antibiotic resistance of pathogens in post-earthquake traumatic infections: A systematic review and meta-analysis.

Rastegar Hoseini | Public Health | Best Researcher Award

Published on by Health Scientists

Assist. Prof. Dr. Rastegar Hoseini | Public Health | Best Researcher Award 

 Physiology | Razi University | Iran

Dr. Rastegar Hosseini is an accomplished academic and researcher in the field of Sport Physiology, with a specialized focus on Sports Nutrition. Serving as a faculty member at the Faculty of Sport Sciences, Razi University, Kermanshah, he has established a strong reputation for his work at the intersection of nutrition, exercise physiology, and athletic performance. His scholarly contributions reflect a commitment to advancing knowledge in exercise metabolism, dietary strategies, and physiological adaptations to training. Through extensive peer-reviewed publications in internationally indexed journals, Dr. Hosseini has contributed significantly to understanding the complex biochemical and nutritional determinants of performance and recovery in athletes. His research emphasizes the translation of laboratory findings into evidence-based nutritional protocols that enhance performance outcomes, promote metabolic health, and support sustainable athletic development. In addition to his academic output, he has been actively involved in national collaborations with sports federations, wellness centers, and interdisciplinary health networks, where his expertise has informed training methodologies and dietary planning. As a mentor and educator, Dr. Hosseini continues to guide postgraduate research projects that explore innovative nutritional interventions and metabolic adaptations in sport and exercise science. His work embodies a balanced integration of scientific rigor, practical application, and educational leadership, contributing meaningfully to both the academic community and the broader field of applied sports science. Through his collaborations with research groups across Iranian universities and active participation in national health and performance initiatives, he has reinforced the importance of science-driven approaches in optimizing human performance and well-being. Dr. Hosseini’s professional affiliations with leading sport physiology and nutrition societies further underscore his dedication to research excellence, academic integrity, and the advancement of knowledge that benefits both elite athletes and the general population through improved understanding of nutrition and exercise physiology. He has 417 citations from 52 documents with an h-index of 12.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Vitamin D and exercise improve VEGF-B production and IGF-1 levels in diabetic rats: Insights into the role of miR-1 suppression. (2025).

2. The role of the SIRT1 and mTOR pathways in exercise-induced β-cell senescence reduction in type 2 diabetes mellitus. (2025).

3. Kynurenine pathway modulation by exercise in multiple sclerosis: Implications for neuroprotection and inflammation. (2025).

4. Combined effects of sodium alginate supplementation with HIIT and MICT on CCK and PYY levels in men with metabolic syndrome. (2025). 

5. Demographic, cultural, and health correlates of physical activity and sports participation among adults in Kermanshah province, Iran. (2025).